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Febrile ulceronecrotic Mucha-Habermann disease
(FUMHD) is a rare, potentially fatal, severe variant of
pityriasis lichenoides et varioliformis acuta (PLEVA).
Lesions of FUMHD usually start with erythematous
papules and plaques that rapidly progress to
form large, often coalescing necrotic ulcers with
hemorrhagic crusts. The skin findings are typically
accompanied by systemic symptoms including high
fever, abdominal pain, diarrhea, arthritis, pulmonary
involvement, central nervous system symptoms, and
sepsis. These systemic manifestations can lead
eventually to serious complications or even a fatal
outcome.1-3
Fatal cases were confined to adults (9 deaths of
about 70 reported cases). On the contrary, children
with FUMHD tend to have amore favorable outcome
than adults, and no deaths have so far been reported
in children.2,3 Here we report the first case, to our
knowledge, of a child with FUMHD complicated by
sepsis that resulted in multiple organ failure and
death.
CASE REPORT
A 9-year-old boy presented with a 1-month
history of a painful skin eruption that started on the
abdomen then progressed over a fewweeks to cover
almost the entire body. The eruption was associated
with fever (398C) and generalized malaise. Skin
examination found widely distributed erythematous
macules, papules, and necrotic plaques with
hemorrhagic crusts (Fig 1). Flexural accentuation of
the lesions was noticed in the axillae, groin, and neck
(Fig 2). The oral mucosawas also involvedwith small
painful ulcers on the tongue and inner lip (Fig 3).
Results of routine laboratory investigations were
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madnofal5@hotmail.com.erythrocyte sedimentation rate and C-reactive
protein, and anemia. A skin biopsy specimen taken
from a necrotic plaque showed focal full-thickness
epidermal necrosis, exocytosis, and vacuolar
interface dermatitis consistent with PLEVA. The
dermis showed prominent superficial and deep
perivascular lymphocytic infiltrate and focal
hemorrhage (Fig 4). Based on correlation of the
clinico-pathologic features, the diagnosis of FUMHD
was made. The patient was admitted to the hospital
and received systemic antibiotics (azithromycin,
250 mg/d) and systemic steroids (30 mg/d) with
almost no response. However, he left the hospital
after 10 days and returned 3 weeks later. During this
period, he had been treated at another hospital
with intravenous immunoglobulins (IVIG) and
cyclosporine that had been stopped after 1 week
because of worsening skin lesions and impaired
renal function.
Despite these treatments, the ulceronecrotic
papules and plaques increased in number and size
and became confluent, covering almost the entire
body surface (Fig 5). The ulcerative lesions became
secondarily infected with Pseudomonas aeruginosa,
which was cultured from the skin and blood. ThisJAAD Case Reports 2016;2:181-5.
2352-5126
 2016 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
http://dx.doi.org/10.1016/j.jdcr.2016.03.002
181
Fig 1. Febrile ulceronecrotic Mucha-Habermann disease.
Generalized ulceronecrotic papules and plaques covering
the whole trunk.
Fig 2. Flexural accentuation of the ulceronecrotic lesions
on the neck.
Fig 3. Mucosal erosions on the tongue and lips.
JAAD CASE REPORTS
MARCH 2016
182 Nofal et alinfection resulted in the development of gangrenous
ulcers covered with central black eschars and sur-
rounded by erythematous borders, features consis-
tent with those of ecthyma gangrenosum classically
associated with Pseudomonas septicemia (Fig 6).
Accordingly, the patient was transferred to the
intensive care unit and given systemic vancomycin
and gentamycin. Over the next few days, he
continued to deteriorate and showed signs of
systemic inflammatory response syndrome
including tachypnea, tachycardia, and hypothermia.
Supportive measures and intravenous fluids were
given, but refractory hypotension, myocardial
dysfunction, and generalized edema followed.Fulminant sepsis led eventually to multiple organ
failure and death.DISCUSSION
An up-to-date literature review of FUMHD found
that about 36 pediatric cases are reported. Analysis
of these cases found an age range of 21 months to
18 years, a higher incidence in boys than girls (27 vs 9,
respectively), anda suspectedetiology inonly 6 cases.
Generalized ulceronecrotic lesions associated with
fever and histopathology consistent with PLEVAwere
found in all patients. Mucousmembrane involvement
was found in 10 cases (28%), and systemic involve-
ment was observed in 16 cases (45%). Combined
therapy was the rule except in 2 patients, and
complete recovery occurred in all cases.1-3
FUMHD in children differs from that in adults by
its more rapid transformation from PLEVA to
FUMHD, less mucosal involvement, more frequent
vasculitis, and more favorable outcome than in adult
cases.4 FUMHD often starts as classic PLEVA and
evolves rapidly to the fulminant widely distributed
ulceronecrotic lesions associated with severe
constitutional manifestations.2 Therefore, it has
been proposed that patients with PLEVA should be
advised to immediately consult their physician if they
have fever and if severe ulcerations develop in their
lesions to allow early diagnosis and prompt therapy.2
On the other hand, some patients present with the
typical lesions of FUMHD from the onset without
previous PLEVA, as was the case in our patient and
some other reported cases.2,3
Lesions of FUMHD closely simulate those of
Stevens-Johnson syndrome, which can also present
with rapidly progressing necrotic lesions and
mucosal involvement. Moreover, both share many
common histopathologic features, including inter-
face dermatitis and dyskeratotic keratinocytes. These
features actually occurred in our patient who had
Stevens-Johnson syndrome diagnosed at another
hospital and received IVIG without any response.
Fig 4. A, Histopathologic examination of a necrotic plaque shows full-thickness epidermal
necrosis, prominent lymphocytic infiltrate, and focal hemorrhage. B, Histopathologic exam-
ination of a nonnecrotic lesion shows keratinocytes necrosis, exocytosis, and vacuolar interface
dermatitis. (A and B, Hematoxylin-eosin stain; original magnifications: A, 3100; B, 3400.)
Fig 5. Severe confluent ulceronecrotic plaques covering
most of the total body surface area.
Fig 6. Multiple ecthyma gangrenosum lesions associated
with Pseudomonas septicemia.
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features include varicella, papulo-vesicular rosea,
leukocytoclastic vasculitis, and lymphomatoid
papulosis.2,3 However, the severe necrotic nature
of the lesions, the flexural accentuation, the
associated constitutional manifestations, and the
clinico-pathologic correlation help to differentiate
between FUMHD and these disorders.
The mortality rate of FUMHD is about 13% of the
reported cases, and all were in adult patients5-11
(Table I).The mortality rate increased with the age of
the patients, where 7 of the 9 fatal cases were older
than 40 years. Therefore, it has been suggested that
early intervention in patients of younger ages may
result in a favorable outcome.3 Fatal outcomes
in adults have been attributed to pulmonary
thromboembolism, pneumonia, sepsis, hypovole-
mic shock, cardiac arrest and thrombosis of superior
mesenteric artery.4-9Secondary infection of the lesions is a common
finding in FUMHD, and sepsis was the cause of death
in our patient as well as in 6 of 9 cases associatedwith
a fatal outcome.8-11
Treatment modalities include methotrexate, an-
tibiotics, acyclovir, dapsone, phototherapy, high-
dose corticosteroids, IVIG, cyclosporine, and in-
fliximab. However, there is no consensus
regarding the most effective therapy because of
the uncertain etiology, the few cases reported, the
combination therapy often used, and the variable
response to the same drug between affected
patients.2,3
Although systemic steroids, cyclosporine, and
IVIG have been previously used with success in the
Table I. Summary of fatal cases of FUMHD
Study Age/y Sex Possible etiology Clinical features* Therapy
Hoghton et al, 19895 49 Female Unknown MI: Negative
SI: SPM, myocarditis,
pulmonary embolism
SS, ATB, DDS, MTX,
UVR, acyclovir
De Cuyper et al, 19946 82 Female Unknown MI: Positive
SI: Megaloblastic anemia,
pneumonia
SS, ATB, UVB
Gungor et al, 19967 59 Male MI: Negative
SI: Abdominal pain, diarrhea
SS, MTX, ATB
Puddu et al, 19978 43 Female Unknown MI: Negative
SI: Sepsis
SS, ATB
Miyamoto et al, 20039 76 Male Monoclonal T cell MI: Negative
SI: Hypovolemic shock, sepsis
ABS
Cozzio et al, 200410 72 Male Monoclonal T cell MI: Negative
SI: Sepsis, pancytopenia
MTX, IVIG
Cozzio et al, 200410 26 Female Monoclonal T cell MI: Negative
SI: Sepsis, pancytopenia
SS, MTX, PUVA
Aytekin et al, 200511 27 Female Unknown MI: Negative
SI: Sepsis
SS, ATB, IVIG, acyclovir
Malnar et al, 200612 60 Male Unknown MI: Positive
SI: Sepsis, pulmonary
thromboembolism,
thrombosis of superior
mesenteric artery
SS, ATB
ABS, Antibiotics; DDS, diamino-diphenyl sulphone; MI, mucosal involvement; MTX, methotrexate; SI, systemic involvement; SS, systemic
steroids.
Adapted from Nofal A, Assaf M, Alakad R, Amer H, Nofal E, Yosef A. Febrile ulceronecrotic Mucha-Habermann disease: proposed diagnostic
criteria and therapeutic evaluation. Int J Dermatol. http://dx.doi.org/10.1111/ijd.13195. Published online December 23, 2015.
*Fever and severe generalized, progressive ulceronecrotic papules and plaques were constant clinical features in all patients.
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did not respond well to these therapeutic agents.
Therefore, we propose that the use of combined
aggressive immunosuppressive therapy, in the
absence of strong evidence for their efficacy, can
lead to impaired immunity and overwhelming
infection ending with sepsis, as was the case in our
patient. In this respect, methotrexate, which is a
less-aggressive immunosuppressive agent, seems to
be the most successful therapy in the reported
cases.2,13,14
The marked severity of the condition, the misdi-
agnosis, and the combined aggressive therapies
represent potential reasons for the fatal outcome in
our patient. However, no definite conclusion can be
given in this respect, and it seems that no interven-
tion could have prevented this terrible outcome.
We propose that early diagnosis and hospitaliza-
tion, surveillance for systemic infection, proper skin
care for ulceronecrotic lesions, and the prudent use
of systemic therapy are among factors that might
prevent mortality in FUMHD.REFERENCES
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